AAAAAA
Results: 26-50/55
Authors:
Revuz, J
Reinert, P
Dupuy, A
Villejuif, IGR
Bernard, P
Brun-Buisson, C
Grenier, B
Lorette, G
Citation: J. Revuz et al., NSAID-induced necrotizing fasciitis, ANN DER VEN, 127(10), 2000, pp. 879-883
Authors:
Bagot, M
Revuz, J
Citation: M. Bagot et J. Revuz, High-risk behaviour, LANCET, 355(9214), 2000, pp. 1555-1556
Authors:
Revuz, J
Citation: J. Revuz, Oesophageal involvement in pemphigus vulgaris, LANCET, 355(9204), 2000, pp. 656-656
Authors:
Bastuji-Garin, S
Fouchard, N
Bertocchi, M
Roujeau, JC
Revuz, J
Wolkenstein, P
Citation: S. Bastuji-garin et al., SCORTEN: A severity-of-illness score for toxic epidermal necrolysis, J INVES DER, 115(2), 2000, pp. 149-153
Authors:
Beneton, N
Wolkenstein, P
Bagot, M
Cosnes, A
Wechsler, J
Roujeau, JC
Revuz, J
Citation: N. Beneton et al., Amicrobial pustulosis associated with autoimmune diseases: healing with zinc supplementation, BR J DERM, 143(6), 2000, pp. 1306-1310
Authors:
Bouloc, A
Grange, F
Delfau-Larue, MH
Dieng, MT
Tortel, MC
Avril, MF
Revuz, J
Bagot, M
Wechsler, J
Citation: A. Bouloc et al., Leucoderma associated with flares of erythrodermic cutaneous T-cell lymphomas: four cases, BR J DERM, 143(4), 2000, pp. 832-836
Authors:
Wolkenstein, P
Durand-Zaleski, I
Moreno, JC
Zeller, J
Hemery, F
Revuz, J
Citation: P. Wolkenstein et al., Cost evaluation of the medical management of neurofibromatosis 1: a prospective study on 201 patients, BR J DERM, 142(6), 2000, pp. 1166-1170
Authors:
Bouloc, A
Revuz, J
Bagot, M
Wechsler, J
Natta, P
Citation: A. Bouloc et al., KH 1060 for the treatment of lichen planus: A multicenter, randomized, double-blind, vehicle-controlled study, ARCH DERMAT, 136(10), 2000, pp. 1272-1272
Authors:
Wolkenstein, P
Revuz, J
Citation: P. Wolkenstein et J. Revuz, Allergic emergencies encountered by the dermatologist - Severe cutaneous adverse drug reactions, CL R ALL IM, 17(4), 1999, pp. 497-511
Authors:
Gollnick, HPM
Finzi, AF
Marks, R
Barker, JNWN
Jansen, C
Revuz, J
Saurat, JH
Citation: Hpm. Gollnick et al., Optimising the use of tazarotene in clinical practice: Consensus statementfrom the European Advisory Panel for Tazaroten (Zorac (TM)), DERMATOLOGY, 199(1), 1999, pp. 40-46
Authors:
Bouloc, A
Godeau, G
Zeller, J
Wechsler, J
Revuz, J
Cosnes, A
Citation: A. Bouloc et al., Increased fibroblast elastase activity in acquired cutis laxa, DERMATOLOGY, 198(4), 1999, pp. 346-350
Authors:
Verpilleux, MP
Bastuji-Garin, S
Revuz, J
Citation: Mp. Verpilleux et al., Comparative analysis of severe aphthosis and Behcet's disease: 104 cases, DERMATOLOGY, 198(3), 1999, pp. 247-251
Authors:
Mauger, D
Zeller, J
Revuz, J
Wolkenstein, P
Citation: D. Mauger et al., Psychological impact of neurofibromatosis type I: analysis of interviews with 12 patients to evaluate quality of life, ANN DER VEN, 126(8-9), 1999, pp. 619-620
Authors:
Bagot, M
Terki, N
Bacha, S
Moyse, D
Suck, C
Revuz, J
Citation: M. Bagot et al., Per os desensitization for nickel contact hypersensitivity double-blind placebo-controlled clinico-biological study, ANN DER VEN, 126(6-7), 1999, pp. 502-504
Authors:
Revuz, J
Wechsler, J
Vaillant, L
Vignon-Pennamen, MD
Price, ML
Perrin, C
Litoux, P
Grosshans, E
Citation: J. Revuz et al., Should we stop using the term "toxidermia" in pathology reports?, ANN DER VEN, 126(4), 1999, pp. 376-379
Authors:
Revuz, J
Citation: J. Revuz, What is the role of "practicaI guidelines"?, ANN DER VEN, 126(3), 1999, pp. 207-209
Authors:
Djien, V
Bocquet, H
Dupuy, A
Revuz, J
Roujeau, JC
Citation: V. Djien et al., Signs and severity markers of erythematous drug reactions, ANN DER VEN, 126(3), 1999, pp. 247-250
Authors:
Le Cleach, L
Benchikhi, H
Liedman, D
Boumsel, L
Wolkenstein, P
Revuz, J
Citation: L. Le Cleach et al., Recurrent hand, foot and mouth disease in a patient with common variable immunodeficiency, ANN DER VEN, 126(3), 1999, pp. 251-253
Authors:
Rodolakis, P
Revuz, J
Benichou, C
Chichmanian, RM
Vaillant, L
Bonnetblanc, JM
Aractingi, S
Citation: P. Rodolakis et al., Do late-onset drug-induced erythematous reactions exist?, ANN DER VEN, 126(2), 1999, pp. 187-190
Authors:
Bocquet, H
Farmer, M
Bressieux, JM
Barzegar, C
Jullien, M
Soto, B
Roujeau, JC
Revuz, J
Citation: H. Bocquet et al., Lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis., ANN DER VEN, 126(1), 1999, pp. 46-48
Authors:
Assier-Bonnet, H
Revuz, J
Citation: H. Assier-bonnet et J. Revuz, Chloroacetamide as a cause of contact dermatitis in hairdressing, CONTACT DER, 40(5), 1999, pp. 284-285
Authors:
Bouloc, A
Wechsler, J
Delfau-Larue, MH
Revuz, J
Bagot, M
Citation: A. Bouloc et al., Sezary syndrome revealed by routine blood examination, BR J DERM, 141(4), 1999, pp. 768-769
Authors:
Dumas, V
Roujeau, JC
Wolkenstein, P
Revuz, J
Cosnes, A
Citation: V. Dumas et al., The treatment of mild pemphigus vulgaris and pemphigus foliaceus with a topical corticosteroid, BR J DERM, 140(6), 1999, pp. 1127-1129
Authors:
Wetterwald, E
Le Cleach, L
Michel, C
David, F
Revuz, J
Citation: E. Wetterwald et al., Nevirapine-induced overlap Stevens-Johnson syndrome/toxic epidermal necrolysis, BR J DERM, 140(5), 1999, pp. 980-982
Authors:
Creange, A
Zeller, J
Rostaing-Rigattieri, S
Brugieres, P
Degos, JD
Revuz, J
Wolkenstein, P
Citation: A. Creange et al., Neurological complications of neurofibromatosis type 1 in adulthood, BRAIN, 122, 1999, pp. 473-481